BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 208377)

  • 21. Cyclic nucleotide phosphodiesterase activity in normal mice and mice with retinal degeneration.
    Robb RM
    Invest Ophthalmol Vis Sci; 1979 Oct; 18(10):1097-100. PubMed ID: 225287
    [No Abstract]   [Full Text] [Related]  

  • 22. Presence of a calcium2+-dependent activator of cyclic-nucleotide phosphodiesterase in rat carotid body: effects of hypoxia.
    Hanbauer I; Lovenberg W
    Neuroscience; 1977; 2(4):603-7. PubMed ID: 199858
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of etimizol on rat brain adenyl cylase and 3',5'-adenosine monophosphate phosphodiesterase activity].
    Migas EA; Bul'on VV
    Farmakol Toksikol; 1974; 37(6):710-1. PubMed ID: 4377131
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cyclic adenosine-3',5'-monophosphate and neuronal functions].
    Shtark MB; Kolpakov VG; Fuks BB
    Usp Sovrem Biol; 1974; 78(1):76-91. PubMed ID: 4373980
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of proteolytic enzymes on rabbit heart cyclic nucleotide phosphodiesterases].
    Lazarevich VG; Tkachuk VA
    Dokl Akad Nauk SSSR; 1979; 246(2):492-5. PubMed ID: 223822
    [No Abstract]   [Full Text] [Related]  

  • 26. Cyclic AMP and adenyl cyclase in the developing rat brain.
    Schmidt MJ; Palmer EC; Dettbarn WD; Robison GA
    Dev Psychobiol; 1970; 3(1):53-67. PubMed ID: 4353393
    [No Abstract]   [Full Text] [Related]  

  • 27. Membrane-bound protein modulator and phosphodiesterase.
    Kakiuchi S; Yamazaki R; Teshima Y; Uenishi K; Yasuda S; Kashiba A; Sobue K; Ohshima M; Nakajima T
    Adv Cyclic Nucleotide Res; 1978; 9():253-63. PubMed ID: 208378
    [No Abstract]   [Full Text] [Related]  

  • 28. Cyclic nucleotide phosphodiesterase activity of human liver: is there an altered form in Reye's syndrome?
    Mitchell RA
    Pediatr Res; 1979 Aug; 13(8):945-7. PubMed ID: 225720
    [No Abstract]   [Full Text] [Related]  

  • 29. Activity of 2',3'-cyclic-nucleotide 3'-phosphodiesterase in regions of rat brain during development: quantitative relationship to myelin basic protein.
    Sprinkle TJ; Zaruba ME; McKhann GM
    J Neurochem; 1978 Feb; 30(2):309-14. PubMed ID: 203660
    [No Abstract]   [Full Text] [Related]  

  • 30. [Submicroscopic study of cyclic nucleotide phosphodiesterase activity of normal and pathological mammalian cells].
    Barkhina TG
    Vestn Akad Med Nauk SSSR; 1983; (11):81-5. PubMed ID: 6318470
    [No Abstract]   [Full Text] [Related]  

  • 31. [Purification of cyclic nucleotide phosphodiesterase from the external segments of retinal rods; conjugation of the enzyme with an inhibitor].
    Furaev VV; Dumler IL; Kazimirskiĭ AN; Etingof RN
    Dokl Akad Nauk SSSR; 1978; 243(1):247-50. PubMed ID: 214282
    [No Abstract]   [Full Text] [Related]  

  • 32. Calmodulin-activated phosphodiesterase from vertebrate smooth muscle.
    Head JF; Birnbaum RJ; Kaminer B
    Ann N Y Acad Sci; 1980; 356():33-5. PubMed ID: 6263152
    [No Abstract]   [Full Text] [Related]  

  • 33. Activity and immunocytochemical localization of 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNPase) in primary nerve cell cultures from rat brain.
    Müller HW; Seifert W
    Cell Mol Neurobiol; 1982 Sep; 2(3):241-7. PubMed ID: 6297735
    [No Abstract]   [Full Text] [Related]  

  • 34. Levels of cyclic nucleotides in mouse regional brain following 300 ms microwave inactivation.
    Jones DJ; Stavinoha WB
    J Neurochem; 1977 Apr; 28(4):759-63. PubMed ID: 19560
    [No Abstract]   [Full Text] [Related]  

  • 35. S49 lymphoma wild type and variant clones contain normal calcium dependent regulator.
    Burgess WH; Howlett AC; Kretsinger RH; Gilman AG
    J Cyclic Nucleotide Res; 1978 Jun; 4(3):175-81. PubMed ID: 214461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interaction of calcium agonists and antagonists with Ca-binding proteins and their effect on cyclic nucleotide phosphodiesterase].
    Feoktistov IA; Baldenkov GN; Barannik IV; Cherviakov EB; Larionov NP
    Biokhimiia; 1990 Apr; 55(4):754-9. PubMed ID: 2165822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The localization of 2':3'-cyclic nucleotide 3'-phosphodiesterase in bovine cerebrum by immunofluorescence.
    Sheedlo HJ; Sprinkle TJ
    Brain Res; 1983 Dec; 288(1-2):330-3. PubMed ID: 6318888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A model for the regulation of the calmodulin-dependent enzymes erythrocyte Ca2+-transport ATPase and brain phosphodiesterase by activators and inhibitors.
    Gietzen K; Sadorf I; Bader H
    Biochem J; 1982 Dec; 207(3):541-8. PubMed ID: 6299272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The interactions between calcium-dependent regulator protein of cyclic nucleotide phosphodiesterase and microtubule proteins. I. Effect of calcium-dependent regulator protein on the calcium sensitivity of microtubule assembly.
    Nishida E; Kumagai H; Ohtsuki I; Sakai H
    J Biochem; 1979 May; 85(5):1257-66. PubMed ID: 221450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The peptide activator of cyclic nucleotide phosphodiesterases: its effect on muscle contractile activity].
    Shchelkovnikov SA; Starshinova LA; Garnovskaia MN; Artem'ev NO; Etingof RN
    Biull Eksp Biol Med; 1988 Dec; 106(12):648-50. PubMed ID: 2850035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.